At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Agents that enhance the immune response to foreign molecules, called adjuvants, will likely play a role in developing a successful COVID-19 vaccine, according to Terry D. Connell, PhD, professor of microbiology and immunology.
Genetic susceptibility to mucosal infections with aging. Chelsie Armbruster (Co-Principal Investigator). NIAID-R21. $438,625. 6/1/2020-5/1/2022.
Genetic susceptibility to mucosal infections with aging. Elsa Bou Ghanem (Co-Principal Investigator). NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. $438,625. 6/1/2020-5/1/2022.
Conserved Proteus mirabilis genetic requirements for colonization of the catheterized urinary tract. Chelsie Armbruster (Principal Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,684,580. 9/1/2019-5/1/2024.